Research Article
Assessment of Bone Mineral Density in Male Patients with Chronic Obstructive Pulmonary Disease by DXA and Quantitative Computed Tomography
Table 2
DXA
versus QCT
measurements for total number of vertebrae and patients.
(a) |
| | | Normal | Osteopenic | Osteoporotic |
| Vertebrae () | DXA | 59 (53.1%) | 32 (28.8%) | 20 (18%) | QCT | 26 (23.4%) | 48 (43.2%) | 37 (33.3%) |
| | value | 0.0004 | 0.09 | 0.03 |
| Patients () | DXA | 16 (43.2%) | 12 (32.4%) | 9 (16.2%) | QCT | 8 (21.6%) | 13 (35.1%) | 16 (43.2%) |
| | value | 0.15 | 0.69 | 0.04 |
|
|
(b) |
| Vertebrae | | Normal | Osteopenic | Osteoporotic |
| Stage GOLD I + II () | DXA | 28 (54.9%) | 18 (35.3%) | 5 (9.8%) | QCT | 16 (31.3%) | 22 (43.1%) | 13 (25.4%) |
| | p value | 0.09 | 0.6 | 0.09 |
| Stage GOLD III + IV () | DXA | 31 (51.6%) | 14 (23.3%) | 15 (25%) | QCT | 10 (16.6%) | 26 (43.3%) | 24 (40%) |
| | p value | 0.001 | 0.08 | 0.2 |
|
|
Dual X-ray absorptiometry. Quantitative computed tomography.
|